NUTX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
210.8M
-2.6%
216.5M
+42.7%
151.7M
-43.4%
267.8M
+9.8%
244.0M
Cost of Revenue
0
0
0
0
0
Gross Profit
210.8M
-2.6%
216.5M
+42.7%
151.7M
-43.4%
267.8M
+9.8%
244.0M
Operating Expenses
89.0M
-34.2%
135.2M
+12.0%
120.8M
-12.1%
137.4M
-34.6%
210.3M
R&D
0
0
0
0
0
SG&A
62.3M
+20.1%
51.9M
+196.7%
-53663000
-184.7%
63.3M
-50.3%
127.5M
Operating Income
121.7M
+49.8%
81.3M
+162.8%
30.9M
-76.3%
130.4M
+287.1%
33.7M
EBITDA
127.0M
+46.4%
86.8M
+140.3%
36.1M
-73.3%
135.4M
+247.8%
38.9M
Net Income
96.3M
+53.5%
62.8M
+277.9%
16.6M
-82.8%
96.8M
+499.6%
16.1M
EPS (Basic)
$9.58
+43.0%
$6.70
+301.2%
$1.67
-79.8%
$8.27
+380.3%
$-2.95
EPS (Diluted)
$9.38
+43.9%
$6.52
+307.5%
$1.60
-79.4%
$7.76
+363.1%
$-2.95
Shares (Diluted)
7.0M
-2.2%
7.2M
-3.0%
7.4M
+3.1%
7.2M
+19.7%
6.0M
Nutex Health (NUTX) โ€” Financials